# EDGAR Filing Document

**Accession Number:** 0002010499
**File Stem:** 0001493152-26-012020
**Filing Date:** 2026-3
**Character Count:** 17543
**Document Hash:** f46e8e8c1b7a59eda17450d5ffe90323
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-26-012020.hdr.sgml**: 20260320

**ACCESSION NUMBER**: 0001493152-26-012020

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260320

**DATE AS OF CHANGE**: 20260320

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Diginex Ltd
- **CENTRAL INDEX KEY:** 0002010499
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-94827
- **FILM NUMBER:** 26779423

**BUSINESS ADDRESS:**
- **STREET 1:** SMART-SPACE FINTECH 2, ROOM 3,
- **STREET 2:** UNIT 401-404, CORE C, CYBERPORT,
- **CITY:** TELEGRAPH BAY
- **STATE:** K3
- **ZIP:** 0000000
- **BUSINESS PHONE:** 852 9315 5775

**MAIL ADDRESS:**
- **STREET 1:** SMART-SPACE FINTECH 2, ROOM 3,
- **STREET 2:** UNIT 401-404, CORE C, CYBERPORT,
- **CITY:** TELEGRAPH BAY
- **STATE:** K3
- **ZIP:** 0000000
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Pelham Miles Christian
- **CENTRAL INDEX KEY:** 0002050408

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** FLAT 2, BLOCK F, 18/F LUNG BIK HOUSE
- **STREET 2:** 8 LUNG POON STREET
- **CITY:** DIAMOND HILL
- **PROVINCE COUNTRY:** K3
- **ZIP:** 00000

## Exhibit 99.1

**Exhibit 99.1**

**Joint Filing Agreement**

In accordance with Rule 13d-1(f) under the Securities and Exchange Act of 1934, the persons or entities named below agree to the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the shares of the Issuer and further agree that this joint filing agreement be included as an exhibit to this Schedule 13D. In evidence thereof, the undersigned, being duly authorized, have executed this Joint Filing Agreement as of March 20, 2026.

---

| | |
|:---|:---|
| **Rhino Ventures Limited**,<br> a Cayman Islands company | **Rhino Ventures Limited**,<br> a Cayman Islands company |
| By: | */s/ Miles Pelham* |
| Name: | Miles Pelham |
| Title: | Director |
| **Miles Pelham** | **Miles Pelham** |
| */s/ Miles Pelham* | */s/ Miles Pelham* |

---

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 5)**

**Diginex Ltd**

*(Name of Issuer)*

**Ordinary Shares, par value US$0.00005**

*(Title of Class of Securities)*

**—**

*(CUSIP Number)*

**James A. Prestiano**<br>c/o Loeb & Loeb<br>345 Park Avenue<br>New York NY 10154<br>212-407-4000

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**03/06/2026**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Rhino Ventures Limited** | Name of reporting person<br>**Rhino Ventures Limited** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**WC** | Source of funds (See Instructions)<br>**WC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**CAYMAN ISLANDS** | Citizenship or place of organization<br>**CAYMAN ISLANDS** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**233726315.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**233726315.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**233726315.00** | Aggregate amount beneficially owned by each reporting person<br>**233726315.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**57.7%** | Percent of class represented by amount in Row (11)<br>**57.7%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**CO** | Type of Reporting Person (See Instructions)<br>**CO** | |

---

**Comment for Reporting Person:** * Percentage for Rhino Cayman is based on 405,161,866 ordinary shares outstanding as of March 16, 2026, including the 172,604,339 ordinary shares underlying the warrants held by Rhino Cayman, which are exercisable within the next 60 days.

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Miles Pelham** | Name of reporting person<br>**Miles Pelham** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**PF** | Source of funds (See Instructions)<br>**PF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X0** | Citizenship or place of organization<br>**X0** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**238508555.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**238508555.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**238508555.00** | Aggregate amount beneficially owned by each reporting person<br>**238508555.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**58.9%** | Percent of class represented by amount in Row (11)<br>**58.9%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Comment for Reporting Person:** ** Percentage for Miles Pelham is based on 405,161,866 ordinary shares outstanding as of March 16, 2026, including the 172,604,339 ordinary shares underlying the warrants held by Rhino Ventures Limited, which are exercisable within the next 60 days.

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Ordinary Shares, par value US$0.00005

**(b) Name of Issuer:**
Diginex Ltd

**(c) Address of Issuer's Principal Executive Offices:**
25 Wilton Road, Victoria, London, Greater London, SW1V 1LW, X0, 0000000

This Amendment No. 5 relates to the Schedule 13D filed with the Securities and Exchange Commission (the "Commission") on behalf of Rhino Ventures Limited, a Cayman Islands company ("Rhino Cayman") and Miles Pelham ("Mr. Pelham"), Rhino Cayman are wholly owned and managed by Mr. Pelham and Mr. Pelham has voting and dispositive control over the Ordinary Shares held by Rhino Cayman (the "Schedule 13D"), relating to the Ordinary Shares, $0.00005 par value per share (the "Ordinary Shares") of Diginex Limited, a Cayman Islands exempted company ("Diginex" or the "Issuer"), filed with the Commission on January 30, 2025, as amended on March 27, 2025, as amended on August 29, 2025, and as amended on October 27, 2025 (the "Schedule 13D"). The information set forth in the Schedule 13D is amended by this Amendment No. 5 only as specifically stated. Capitalized terms used but not otherwise defined herein shall have the meaning ascribed to them in the Schedule 13D. The information set forth in response to each separate Item below shall be deemed to be a response to all Items where such information is relevant. As of March 16, 2026, the Issuer had 232,557,527 Ordinary Shares issued and outstanding.

**Item 4. Purpose of Transaction**

The Reporting Persons acquired and hold the securities of the Issuer for investment purposes. Other than as discussed herein, the Reporting Persons do not have any plans or proposals which relate to or would result in: (a) the acquisition by any person of additional securities of the Issuer; (b) an extraordinary corporate transaction, such as a merger, reorganization or liquidation , involving the Issuer or any of its subsidiaries; (c) a sale or transfer of a material amount of assets of the Issuer or of any of its subsidiaries; (d) any change in the present board of directors or management of the Issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board; (e) any material change in the present capitalization or dividend policy of the Issuer; (f) any other material change in the Issuer's business or corporate structure; (g) changes in the Issuer's charter, bylaws or instruments corresponding thereto or other actions which may impede the acquisition of control of the issuer by any other person; (h) causing a class of securities of the Issuer to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association; (i) a class of equity securities of the Issuer becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Securities Act; or (j) any similar action to those enumerated above. The Reporting Persons may acquire additional securities of the Issuer, or retain, or sell all or a portion of the securities then held in open market or in privately negotiated transactions. Mr. Pelham is the Chairman of the Issuer, and, in such capacity, may have influence over the corporate activities of the Issuer, including activities which may relate to the matters described in this Item 4.

**Item 5. Interest in Securities of the Issuer**

**(a)**
Rhino Cayman beneficially owns (i) 61,121,976 Ordinary Shares and (ii) 172,604,339 Ordinary Shares underlying warrants, which are exercisable within the next sixty (60) days, which amounts to 233,726,315 Ordinary Shares or 57.7% of the total outstanding Ordinary Shares. Rhino Cayman owns the following warrants. (i) Rhino Cayman owns 4,170,520 warrants that were issued by the Issuer on July 15, 2024, that are exercisable at a price of US$6.13 per warrant and are exercisable until May 27, 2029 (the "51% Warrant"), which if fully exercised, will result in the issuance of shares equal to 51% of the Issuer's outstanding Ordinary Shares at the time the warrants are exercised and such amount will be prorated in the event of partial exercise of the warrants (for the purpose of this Schedule 13D we have assumed these warrants are exercisable for 118,604,339 Ordinary Shares which is 51% of the 232,557,527 Ordinary Shares the Issuer had issued outstanding as of March 16, 2026), and (ii) On January 23, 2025 the Issuer issued Rhino Cayman the following warrants in connection with the closing of the Issuer's initial public offering: (a). a warrant to purchase 18,000,000 Ordinary Shares, exercisable at a price of $1.03 per share, which is equivalent to 100% premium to the initial public offering price per share, which expire on January 23, 2028 (the "IPO Warrant No. 1"), (b). a warrant to purchase 18,000,000 Ordinary Shares, exercisable at a price of $1.28 per share, which is equivalent to 150% premium to the initial public offering price per share, which expire January 23, 2028 (the "IPO Warrant No. 2"), and (c). a warrant to purchase 18,000,000 Ordinary Shares, exercisable at a price of $1.54 per share, which is equivalent to 200% premium to the initial public offering price per share, which January 23, 2029 (the "IPO Warrant No. 3"). Mr. Pelham beneficially owns (i) 4,782,240 Ordinary Shares in his own name and (ii) 233,726,315 Ordinary Shares beneficially held by Rhino Cayman, which amounts to 238,508,555 Ordinary Shares or 58.9% of the total outstanding Ordinary Shares. Mr. Pelham individually and through his position as director of Rhino Cayman, may be deemed to hold the power to vote or direct the vote and dispose of or direct the disposition of the Ordinary Shares beneficially held by the Reporting Persons.

**(b)**
Rhino Cayman beneficially owns (i) 61,121,976 Ordinary Shares and (ii) 172,604,339 Ordinary Shares underlying warrants, which are exercisable within the next sixty (60) days, which amounts to 233,726,315 Ordinary Shares or 57.7% of the total outstanding Ordinary Shares. Rhino Cayman owns the following warrants. (i) Rhino Cayman owns 4,170,520 warrants that were issued by the Issuer on July 15, 2024, that are exercisable at a price of US$6.13 per warrant and are exercisable until May 27, 2029 (the "51% Warrant"), which if fully exercised, will result in the issuance of shares equal to 51% of the Issuer's outstanding Ordinary Shares at the time the warrants are exercised and such amount will be prorated in the event of partial exercise of the warrants (for the purpose of this Schedule 13D we have assumed these warrants are exercisable for 118,604,339 Ordinary Shares which is 51% of the 232,557,527 Ordinary Shares the Issuer had issued outstanding as of March 16, 2026), and (ii) On January 23, 2025 the Issuer issued Rhino Cayman the following warrants in connection with the closing of the Issuer's initial public offering: (a). a warrant to purchase 18,000,000 Ordinary Shares, exercisable at a price of $1.03 per share, which is equivalent to 100% premium to the initial public offering price per share, which expire on January 23, 2028 (the "IPO Warrant No. 1"), (b). a warrant to purchase 18,000,000 Ordinary Shares, exercisable at a price of $1.28 per share, which is equivalent to 150% premium to the initial public offering price per share, which expire January 23, 2028 (the "IPO Warrant No. 2"), and (c). a warrant to purchase 18,000,000 Ordinary Shares, exercisable at a price of $1.54 per share, which is equivalent to 200% premium to the initial public offering price per share, which January 23, 2029 (the "IPO Warrant No. 3"). Mr. Pelham beneficially owns (i) 4,782,240 Ordinary Shares in his own name and (ii) 233,726,315 Ordinary Shares beneficially held by Rhino Cayman, which amounts to 238,508,555 Ordinary Shares or 58.9% of the total outstanding Ordinary Shares. Mr. Pelham individually and through his position as director of Rhino Cayman, may be deemed to hold the power to vote or direct the vote and dispose of or direct the disposition of the Ordinary Shares beneficially held by the Reporting Persons.

**(c)**
No Reporting Person has effected any transactions of Ordinary Shares of the Issuer in the past sixty (60) days.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

On November 7, 2025, the Issuer issued Mr. Pelham Restrictive Share Units ("RSUs") to acquire 14,164 Ordinary Shares. The RSUs vest 1/3 on March 31, 2026, 1/3 on March 31, 2027, and 1/3 on March 31, 2028, provided certain conditions are satisfied.

On November 7, 2025, the Issuer issued Mr. Pelham Performance Share Units ("PSUs") to acquire 14,164 Ordinary Shares. The PSUs all vest on March 31, 2028, provided certain conditions are satisfied.

Mr. Pelham is a director and the sole shareholder of Rhino Cayman, which is an investment holding company and Mr. Pelham is the Chairman and a shareholder of Diginex Limited. A Joint Filing Agreement is attached hereto as Exhibit 99.1.

On March 20, 2026, the Board of Directors of the Issuer extended the exercise periods for the 51% Warrant, IPO Warrant No. 1, IPO Warrant No. 2, and IPO Warrant No. 3 by two years. Accordingly, the 51% Warrant expires on May 27, 2029, the IPO Warrant No. 1 expires on April 27, 2028, the IPO Warrant No. 2 expires on July 23, 2028, and the IPO Warrant No. 3 expires on January 23, 2029.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Rhino Ventures Limited

**Signature:** /s/ Miles Pelham

**Name/Title:** Miles Pelham/Director

**Date:** 03/20/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Miles Pelham

**Signature:** /s/ Miles Pelham

**Name/Title:** Miles Pelham/Director

**Date:** 03/20/2026